Previous 10 | Next 10 |
Hertz Global (NYSE: HTZ ) +84% on bullish travel updates . More news on: Hertz Global Holdings, Inc., QEP Resources, Inc., Dynagas LNG Partners LP, Stocks on the move, , Read more ...
Tetraphase terminates merger agreement with AcelRx to enter into merger agreement with Melinta Melinta agreement provides for an aggregate of $39.0 million upfront in cash plus potential contingent value rights cash payments of up to $16.0 million Acquisition Expected to Close in ...
AcelRx Pharmaceuticals (NASDAQ: ACRX ) announces that it does not intend to revise its latest cash-and-stock bid for Tetraphase Pharmaceuticals (NASDAQ: TTPH ) and expects the termination of their previously announced merger agreement since the latter's board deemed a competing offer f...
REDWOOD CITY, Calif. , June 3, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (AcelRx) (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that it does...
Gainers: MGI +33.6% . TTPH +11.2% . UBX +7.7% . PRT +6.6% . WU +4.8% . More news on: MoneyGram International, Inc., Tetraphase Pharmaceuticals, Inc., Unity Biotechnology, Inc., Stocks on the move, , Read more ...
Merger activity ground to a halt last week with no new deals announced, three deals closing and one deal called off. This is the third week in the month of May with no new deals announced. There were however, two potential deals announced last week. The COVID-19 pandemic caused another deal ...
Tetraphase Pharmaceuticals ( TTPH -11.1% ) has entered into a second amendment of its merger agreement with AcelRx Pharmaceuticals ( ACRX ) after the latter submitted a revised bid of $0.5872 in cash plus 0.7409 in ACRX stock, representing an offer of ~$1.70 per share ($37M), topping Mel...
ARCA biopharma (NASDAQ: ABIO ) -28% . More news on: ARCA biopharma, Inc., ToughBuilt Industries, Inc., Canopy Growth Corporation, Stocks on the move, , Read more ...
Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a biopharmaceutical company focused on commercializing its novel tetracycline XERAVA TM (eravacycline for injection) to treat serious and life-threatening infections, today announced that it has entered into a second amendment to the Agreement ...
Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a biopharmaceutical company focused on commercializing its novel tetracycline XERAVA TM (eravacycline for injection) to treat serious and life-threatening infections, today announced that its Board of Directors has received a revised proposal f...
News, Short Squeeze, Breakout and More Instantly...
Tetraphase Pharmaceuticals Inc. Company Name:
TTPH Stock Symbol:
NASDAQ Market:
Tetraphase Pharmaceuticals Inc. Website:
SAN DIEGO, California and WATERTOWN, Massachusetts, July 28, 2020 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening disease...
La Jolla agreement provides for $43.0 million in upfront cash plus potential future cash payments of up to $16.0 million pursuant to contingent value rights Combined company will offer two innovative therapies to treat patients suffering from life-threatening diseases SAN DIEGO, Ca...
Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a biopharmaceutical company focused on commercializing its novel tetracycline XERAVA TM (eravacycline for injection) to treat serious and life-threatening infections, today announced that on June 19, 2020, its Board of Directors received an uns...